Abiopharma

News list

📋 O'Byrne Jason (Ex-Officer) plans to sell 23K shares of Vir Biotechnology, Inc. (at $10.48 each, total $243K) Filed: Aug 25, 2026 | ID: 006425

Full text

News bot Aug. 25, 2026, 3:07 p.m.
📋 Form 144 Filing: O'Byrne Jason

Company: Vir Biotechnology, Inc.

Filing Date: 2026-08-25

Relationship: Former Officer
Planned Sale Details:
- Security: Common
- Shares to be Sold: 23,148
- Price per Share: $10.48
- Total Value: $242,591.04
- Planned Sale Date: 2026-08-25
- Broker: Fidelity Brokerage Services LLC
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-39083
- Issuer Contact Phone: 415-906-4324
- Issuer Address: 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
- Broker Address: 900 Salem Street, Smithfield, RI, 02917
- Shares Outstanding: 169215958.0
- Number of Securities to be Sold: 1
- Number of Past Sales: 2
- Signature: /s/ Jessica Spraker, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Jason V. O'Byrne.